Cited by 1,101Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesSexual Differentiation and DisordersImmunodeficiency and Autoimmune Disorders

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner syndrome meeting

Open access
Gravholt, Claus H, Andersen, Niels H, Conway, Gerard S, Dekkers, Olaf M, Geffner, Mitchell E, Klein, Karen O, Lin, Angela E, Mauras, Nelly +11 more·2017·European Journal of Endocrinology

Abstract

Turner syndrome affects 25-50 per 100,000 females and can involve multiple organs through all stages of life, necessitating multidisciplinary approach to care. Previous guidelines have highlighted this, but numerous important advances have been noted recently. These advances cover all specialty fields involved in the care of girls and women with TS. This paper is based on an international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016. Prior to this meeting, five groups each addressed important areas in TS care: 1) diagnostic and genetic issues, 2) growth and development during childhood and adolescence, 3) congenital and acquired cardiovascular disease, 4) transition and adult care, and 5) other comorbidities and neurocognitive issues. These groups produced proposals for the present guidelines. Additionally, four pertinent questions were submitted for formal GRADE (Grading of Recommendations, Assessment, Development and Evaluation) evaluation with a separate systematic review of the literature. These four questions related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy. The guidelines project was initiated by the European Society for Endocrinology and the Pediatric Endocrine Society, in collaboration with The European Society for Pediatric Endocrinology, The Endocrine Society, European Society of Human Reproduction and Embryology, The American Heart Association, The Society for Endocrinology, and the European Society of Cardiology. The guideline has been formally endorsed by the European Society for Endocrinology, the Pediatric Endocrine Society, the European Society for Pediatric Endocrinology, the European Society of Human Reproduction and Embryology and the Endocrine Society. Advocacy groups appointed representatives who participated in pre-meeting discussions and in the consensus meeting.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-17-0430

Cites

579 of 580 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous important advances in TS care have been noted since the publication of previous guidelines.

    “Previous guidelines have already addressed this, but numerous important advances have been noted since their publication.1-3”
  • Comparative studies of karyotype-phenotype in TS are challenged by relatively small cohorts, differences in patient ages, variability in the definition of the clinical features, and general uncertainty regarding the extent of mosaicism in different tissues.

    “Comparative studies of karyotype-phenotype in TS are challenged by relatively small cohorts, differences in patient ages, variability in the definition of the clinical features, and general uncertainty regarding the extent of mosaicism in different tissues.1”
  • In 10%-12% of individuals with TS, a normal or structurally abnormal Y chromosome can be detected by karyotyping, FISH using Y-chromosome probes, PCR with Y-specific probes, or array-comparative genomic hybridization (array-CGH).

    “In 10%-12% of individuals with TS, a normal or structurally abnormal Y chromosome can be detected by karyotyping, FISH using Y-chromosome probes, PCR with Y-specific probes, or array-comparative genomic hybridization (array-CGH).”
  • PCR is more sensitive in detecting Y material than FISH.

    “PCR is more sensitive in detecting Y material than FISH”
  • Studies differ on whether oral E2 vs TD E2 leads to increased total cholesterol and decreased HDL.

    “Studies differ on whether oral E2 vs. TD E2 leads to increased total cholesterol and decreased HDL”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Eds MB Ranke & RG Rosenfeld. Amsterdam: Elsevier Science Publishing, 2016.
  2. Bright Futures. Guidelines for Health Supervision of Infants, Children and Adolescents. Third edition ed. Elk Grove Village, IL: American Academy of Pediatrics, 2008. 463
  3. Pennington BF, Bender B, Puck M, Salbenblatt J & Robinson A. Learning disabilities in children with sex chromosome anomalies. Child Development 1982 53 1182-1192. (doi:10.2307/1129006) 566 · DOI

Cited by

Sorted by citations

Authors
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., Sandberg, D. E., Sas, T. C. J., Silberbach, M., Söderström-Anttila, V., Stochholm, K., van Alfen-van derVelden, J. A., Woelfle, J., Backeljauw, P. F., & _, _.
Affiliations
  • 1Departments of Endocrinology and Internal Medicine
  • Aarhus University Hospital (DK)
  • University College London (GB)
  • Leiden University Medical Center (NL)
  • Children's Hospital Los Angeles (US)
  • University of California San Diego (US)
  • Massachusetts General Hospital (US)
  • Nemours Children's Health System (US)
  • 10St Hubert’s Island, New South Wales, Australia
  • Connecticut Children's Medical Center (US)
  • University of Michigan (US)
  • Erasmus MC - Sophia Children’s Hospital (NL)
  • Doernbecher Children's Hospital (US)
  • 16Väestöliitto Fertility Clinics, Helsinki, Finland
  • 18Department of Pediatric Endocrinology, Radboud University Medical Center, Amalia Children’s Hospital, Nijmegen, The Netherlands
  • University of Bonn (DE)
  • Cincinnati Children's Hospital Medical Center (US)
Corresponding author
Gravholt, Claus H
Venue
European Journal of Endocrinology
Published
2017-09
Volume
177
Issue
3
Pages
G1-G70
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2735815275
Cited by
1,101
References
580
Citations by year
2026: 37 · 2025: 82 · 2024: 170 · 2023: 159 · 2022: 123 · 2021: 144 · 2020: 148 · 2019: 151 · 2018: 74 · 2017: 9 · 2015: 1
FWCI
13.52
Type
journal article
Language
en
Open access
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • Scopus (Elsevier) (submittedVersion)
Funders
  • Novo Nordisk Fonden (NNF13OC0003234, NNF15OC0016474)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R13HD089663)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
Turner syndrome, short stature, infertility, hypertension, hormone replacement therapy, cardiovascular disease, adult care, transition to adult care, neurocognitive function, comorbidities, growth and development, multidisciplinary care
MeSH terms
Congresses as Topic, Europe, Female, Patient Care, Humans, Ohio, Turner Syndrome, United States, Women, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review